aav5-hfix
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2015 (NCT02396342)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor IXSupplementation
F9 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aav5-hfix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03569891 | Phase 3 | Jun 27, 2018 | UniQure N.V., University of Michigan |
| NCT02396342 | Phase 1/Phase 2 (Phase 2) | May 1, 2015 | Chiesi, UniQure N.V. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| UniQure N.V. | For profit | 2 | 2 | 2 | 2015 |
| Chiesi | For profit | 1 | 0 | 1 | 2015 |
| University of Michigan | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1